Physician profile
Samuel S Lee
NPI 1194772418
$15,868.51
in general payments reported to CMS, 2019-2025
32 companies · $4,386 in 2025
The $4,386 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $266 · 2021: $1,052 · 2022: $2,107 · 2023: $3,778 · 2024: $3,285 · 2025: $4,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,898 · Travel and Lodging: $3,551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,898.49 |
| Travel and Lodging | $3,551.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,232.52 | 2021-2025 | Interstim |
| Teleflex LLC | $3,353.43 | 2022-2025 | Urolift, Barrigel, Solesta |
| Palette Life Sciences, INC. | $1,171.60 | 2023 | |
| Caldera Medical, INC | $838.35 | 2021-2024 | Desara |
| Medtronic USA, INC. | $794.52 | 2019-2020 | |
| Abbott Laboratories | $770.08 | 2021-2025 | Proclaim, Eterna |
| Axonics, INC. | $619.03 | 2023-2024 | Axonics |
| Procept Biorobotics Corporation | $498.64 | 2024-2025 | Aquabeam System |
| Boston Scientific Corporation | $461.47 | 2019-2025 | Axonics, Solyx Sis System |
| Novo Nordisk INC | $349.67 | 2021-2025 | Wegovy |
| Madrigal Pharmaceuticals | $296.50 | 2025 | Rezdiffra |
| Coloplast Corp | $289.75 | 2020-2025 | |
| Olympus America INC. | $282.91 | 2024-2025 | Soltive, Uretero-Reno Fiberscope, Bovie |
| Sumitomo Pharma America, INC. | $282.30 | 2023-2025 | Orgovyx, Gemtesa |
| Phathom Pharmaceuticals, INC. | $250.00 | 2024-2025 | Voquezna |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $175.16 | 2019-2025 | |
| Laborie Medical Technologies Corp. | $166.84 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Janssen Biotech, INC. | $157.47 | 2019-2024 | Erleada, Akeega |
| Endo Pharmaceuticals INC. | $135.86 | 2019-2023 | Xiaflex |
| Regeneron Healthcare Solutions, INC. | $135.00 | 2025 | Dupixent |
| Smith+Nephew, INC. | $115.22 | 2022 | |
| Astellas Pharma US INC | $111.25 | 2019-2022 | |
| Gilead Sciences, INC. | $100.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.89 | 2022 | |
| Progenics Pharmaceuticals, INC. | $51.63 | 2025 | |
| Rochester Medical Corporation | $51.61 | 2022 | |
| Myovant Sciences INC. | $35.78 | 2022 | |
| 180 Medical, INC. | $26.95 | 2023 | |
| Accord Healthcare, INC. | $20.22 | 2024 | |
| Hollister Incorporated | $18.75 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $16.61 | 2019 | |
| Ambu INC. | $2.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.